Note: Ingredients listed on restricted chemical lists
EC/CAS
13463-67-7
Name of the chemical
Reaction mass of titanium dioxide and silver chloride
Concentration
N/A
General Information
Revision date
2013-06-14
Product name
Prometrium; Utrogestan
Product Synonyms
Utrogestan Capsules; Prometrium Capsules, 100 mg; Prometrium Capsules, 200 mg; Utrogestan Capsules, 100 mg; Utrogestan Capsules, 200 mg
supplier name
AbbVie Inc
Icons in SDS
Company Information
company name
AbbVie Inc
e-mail address of the competent person responsible for the Safety Data Sheet
AbbVie.SDS@abbvie.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H351, H360
Hazard statements
Code
Statements
H351
Suspected of causing cancer
Section 2
2.1 Classification of the substance or mixture
Regulation (EC) No 1272/2008 Reproductive toxicity Category 1A Carcinogenicity Category 2
EU Classification
Directives 67/548/EEC or 1999/45/EC
Hazard statements
R40 - Limited evidence of a carcinogenic effect R61 - May cause harm to the unborn child H351 - Suspected of causing cancer H360 - May damage fertility or the unborn child P201 - Obtain special instructions before use P202 - Do not handle until all safety precautions have been read and understood P281 - Use personal protective equipment as required P308 + P313 - IF exposed or concerned: Get medical advice/attention P405 - Store locked up P501 - Dispose of contents/container to an approved waste disposal plant
Signal word
Danger
2.3 Other hazards
Not determined
